Market capitalization | DKK28.46b |
Enterprise Value | DKK28.41b |
P/E (TTM) P/E ratio | 121.09 |
EV/FCF (TTM) EV/FCF | 39.18 |
EV/Sales (TTM) EV/Sales | 5.27 |
P/S ratio (TTM) P/S ratio | 5.28 |
P/B ratio (TTM) P/B ratio | 5.09 |
Dividend yield | 0.36% |
Last dividend (FY24) | DKK0.38 |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
11 Analysts have issued a Ambu forecast:
11 Analysts have issued a Ambu forecast:
Sep '24 |
+/-
%
|
||
Revenue | 5,391 5,391 |
13%
13%
|
|
Gross Profit | 3,151 3,151 |
16%
16%
|
|
EBITDA | 1,007 1,007 |
69%
69%
|
EBIT (Operating Income) EBIT | 311 311 |
3%
3%
|
Net Profit | 235 235 |
40%
40%
|
In millions DKK.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single lung ventilation procedure, or a bedside bronchoscopy procedure in the intensive care unit . The company was founded by Holger Hesse in 1937 and is headquartered in Ballerup, Denmark.
Head office | Denmark |
CEO | Britt Jensen |
Employees | 5,196 |
Founded | 1937 |
Website | www.ambu.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.